MediPress Health-Limited Partnership (TLV:MPRS)

Market Cap	8.09M -36.1%
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	15.01M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	142,304
Open	55.40
Previous Close	n/a
Day's Range	53.50 - 55.50
52-Week Range	37.80 - 75.70
Beta	0.33
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About TLV:MPRS

MediPress Health-Limited Partnership, is a research and development life science partnership and venture capital firm specializing in seed/startups investments. The firm seeks to invest in medical research and development companies. Its portfolio companies engage in the treatment of cancer with proton radiation therapy; and the development of non-surgical vaginal solutions for women with various pelvic floor disorders. The firm seeks to take board positions in its portfolio companies. MediPress Health-Limited Partnership was incorporated in 202...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2021
• Country: Israel
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: MPRS

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 24, 2026

Data Sources Report a data error